Your Article Summary
Cempra Pharmaceuticals Raises $14 Million Round of Financing
Corporate News Releases - The Healthcare Sales & Marketing Network, 08/17/06
Cempra Pharmaceuticals, a biotechnology company developing anti-infective medicines, announced that it has closed a $14 million financing round. Venture capital firm Intersouth Partners and investment banker I. Wistar Morris, III co-led the Series A round
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Prodesses ProParaflu+(TM) Assay Cleared for US Marketing by FDA
Gen-Probe, 12/03/09
Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
Shire, 12/03/09
Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09
Article Search
Sponsor


See Latest Articles


